Bruker Corp (BRKR)
78.04
+0.28
(+0.36%)
USD |
NASDAQ |
Apr 22, 16:00
78.06
+0.02
(+0.03%)
Pre-Market: 20:00
Bruker Debt to Equity Ratio: 0.9305 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.9305 |
September 30, 2023 | 1.009 |
June 30, 2023 | 1.010 |
March 31, 2023 | 1.041 |
December 31, 2022 | 1.095 |
September 30, 2022 | 1.231 |
June 30, 2022 | 1.221 |
March 31, 2022 | 1.196 |
December 31, 2021 | 1.246 |
September 30, 2021 | 0.7689 |
June 30, 2021 | 0.8276 |
March 31, 2021 | 0.8517 |
December 31, 2020 | 0.8786 |
September 30, 2020 | 0.8717 |
June 30, 2020 | 1.142 |
March 31, 2020 | 1.104 |
December 31, 2019 | 0.8969 |
September 30, 2019 | 0.6138 |
June 30, 2019 | 0.5741 |
March 31, 2019 | 0.3664 |
December 31, 2018 | 0.3804 |
September 30, 2018 | 0.2945 |
June 30, 2018 | 0.2841 |
March 31, 2018 | 0.2823 |
December 31, 2017 | 0.5729 |
Date | Value |
---|---|
September 30, 2017 | 0.6566 |
June 30, 2017 | 0.5701 |
March 31, 2017 | 0.531 |
December 31, 2016 | 0.5998 |
September 30, 2016 | 0.5259 |
June 30, 2016 | 0.5171 |
March 31, 2016 | 0.4304 |
December 31, 2015 | 0.3661 |
September 30, 2015 | 0.4885 |
June 30, 2015 | 0.4792 |
March 31, 2015 | 0.4954 |
December 31, 2014 | 0.4635 |
September 30, 2014 | 0.4399 |
June 30, 2014 | 0.4041 |
March 31, 2014 | 0.4113 |
December 31, 2013 | 0.4196 |
September 30, 2013 | 0.4577 |
June 30, 2013 | 0.4681 |
March 31, 2013 | 0.4884 |
December 31, 2012 | 0.4772 |
September 30, 2012 | 0.4864 |
June 30, 2012 | 0.5024 |
March 31, 2012 | 0.4853 |
December 31, 2011 | 0.4877 |
September 30, 2011 | 0.5194 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5741
Minimum
Jun 2019
1.246
Maximum
Dec 2021
0.9742
Average
1.009
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Azenta Inc | 0.00 |
Harvard Bioscience Inc | 0.5004 |
Bionano Genomics Inc | 0.7259 |
Akoya Biosciences Inc | 1.400 |
Singular Genomics Systems Inc | 0.0497 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.250B |
Total Liabilities (Quarterly) | 2.837B |
Shareholders Equity (Quarterly) | 1.377B |
Current Ratio | 1.800 |
Net Debt Paydown Yield | -0.24% |